PFPG
TEVA icon

Pinnacle Financial Partners (Georgia)’s Teva Pharmaceuticals TEVA Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Hold
14,692
– – ﹤0.01% 849
2026
Q1 		$443K Sell
14,692
-72
-0.5% -$2.32K ﹤0.01% 845
2025
Q4 		$461K Buy
+14,764
New +$364K ﹤0.01% 811

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s TEVA Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 14,692 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Pinnacle Financial Partners (Georgia) first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 14,692 shares of Teva Pharmaceuticals worth $498K as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #849 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.